Key Highlights
- Taiwan is exploring new regulations that would ban AI chip sales to any Chinese entity, extending beyond currently sanctioned companies
- TSM shares declined during premarket trading before reversing course, climbing 2.5% following the U.S. opening bell
- The proposed legislation would criminalize unauthorized AI chip shipments to China under Taiwan’s domestic legal framework
- TSMC’s CEO Che-Chia Wei purchased $11,401 in TSM shares on June 5, paying $76.01 per American Depositary Receipt
- Analysts maintain a consensus “Buy” recommendation on TSM with a mean price objective of $404.29
Taiwan is contemplating a significant overhaul of its AI chip export policies toward China, a development that captured investor attention throughout Tuesday’s trading session.
Shares of TSM began the day at $427.11 and climbed 2.5% following the opening of U.S. markets, erasing earlier premarket losses. The stock’s 52-week trading band stretches from $205.87 to $450.16, illustrating the substantial appreciation over the past year.
Taiwan Semiconductor Manufacturing Company Limited, TSM
According to a Bloomberg report, the contemplated regulations would prohibit AI chip transactions exceeding specific performance thresholds to any Chinese purchaser — expanding well beyond entities currently sanctioned by the United States, such as Huawei.
This represents a substantial policy escalation. While existing U.S. regulations prohibit such transactions, Taiwan currently lacks domestic criminal statutes covering these violations. This jurisdictional gap has constrained Taiwanese officials’ enforcement capabilities when semiconductors reach unauthorized destinations.
The proposed legal framework would empower Taiwan with criminal prosecution authority over illicit AI chip exports for the first time in its history.
Taiwanese authorities only conducted their inaugural arrests of suspected chip smuggling operatives last month, charging defendants solely with document fraud. The contemplated measures would dramatically expand enforcement powers.
These discussions are unfolding within the context of comprehensive trade negotiations between Taiwan and the United States. High-ranking officials from both governments have yet to finalize or authorize any binding agreement, with numerous provisions still under negotiation.
Washington has intensified pressure on this issue. Last week, the Trump administration implemented measures designed to eliminate a regulatory gap potentially allowing sophisticated chips to reach Chinese companies’ foreign subsidiaries.
Congressional Leaders Intensify Demands
On Monday, Senators Jim Banks (R-IN) and Andy Kim (D-NJ) sent correspondence to Jeffrey Kessler, head of the Bureau of Industry and Security, advocating for enhanced restrictions on contract semiconductor manufacturers servicing overseas divisions of Chinese corporations — language clearly targeting firms such as TSMC.
The correspondence highlights mounting Congressional anxiety regarding the redirection of advanced computing hardware, including Nvidia-powered AI servers, from Taiwanese facilities to mainland China.
Executive Share Purchases Continue
Beyond the geopolitical developments, TSMC’s CEO Che-Chia Wei has maintained steady share acquisition activity. On June 5, he acquired 150 ADR shares at $76.01 each, representing a transaction value of $11,401.50. His current holdings total 17,689 shares valued at approximately $1.34 million.
This marks his third consecutive monthly purchase. He acquired 160 shares during May and 186 in April. Sustained insider accumulation at this frequency typically attracts market attention.
TSMC recently announced a dividend increase from $0.95 to $1.1136 per share quarterly — translating to an annualized yield of approximately 1.0%.
Regarding institutional activity, Tiger Global expanded its TSM holdings by 49.4% during Q1, adding more than 1.8 million shares to its portfolio. T. Rowe Price nearly tripled its position in Q4, increasing its stake by 168.6%.
Wall Street analysts maintain a positive outlook. Barclays elevated its price target to $470 with an Overweight designation in April. DA Davidson and Wedbush maintain Buy and Outperform ratings respectively.
The consensus analyst price target reaches $404.29, positioned below current trading levels.


